This document presents the case of an 18-year-old female admitted to the hospital with a 4-month history of fever, headache, weight loss and 15 days of shortness of breath. Examination revealed splenomegaly, bony tenderness and abnormalities in the right lung. Investigations showed pancytopenia, blasts in the blood and bone marrow consistent with precursor B-cell acute lymphoblastic leukemia with Philadelphia chromosome and CNS involvement. Treatment involves supportive care and chemotherapy with induction, consolidation and maintenance phases along with CNS prophylaxis. The prognosis is poor given the adverse features in this case.
leukemia is one among the common congenital malformations in children. it is also called as cancer of blood cells where immature blood cells are formed due to mutations in progenitor stem cell. This content includes types of leukemia especially categorized in children with description of diagnosis and management.
Hodgkin Lymphoma - Diagnosis to ManagementSubhash Thakur
Presentation is about Hodgkin lymphoma, its incidence and epidemiology, diagnosis, molecular and immunophenotype, work up, staging, treatment and follow up
leukemia is one among the common congenital malformations in children. it is also called as cancer of blood cells where immature blood cells are formed due to mutations in progenitor stem cell. This content includes types of leukemia especially categorized in children with description of diagnosis and management.
Hodgkin Lymphoma - Diagnosis to ManagementSubhash Thakur
Presentation is about Hodgkin lymphoma, its incidence and epidemiology, diagnosis, molecular and immunophenotype, work up, staging, treatment and follow up
Hemophagocytic lymphohistiocytosis (hlh), Langerhans cell histiocytosis dr vi...Vijitha A S
Hemophagocytic lymphohistiocytosis (hlh)
Langerhans cell histiocytosis,Benign proliferation of mature histiocytes and uncontrolled phagocytosis of the platelet, erythrocytes, lymphocytes, and their hematopoietic precursors in the bonemarrow & other tissues
Leukemia, were surviving is regarded as a victory, a disease that still acts as a risk factor among the folks of Hiroshima and Nagasaki, stays as one of the fields to be looked forward for the further research. The above presentation includes the topics to be covered during a presentation on Leukemia. Apt for the students of Pharmacology.
It is a malignant disease of a blood forming organs. The common feature of leukemia is an unregulated proliferation of white blood cells (WBCs) in the bone marrow.
complete information about the cancer condition that is leukemia - introduction, definition, etiology and causes, pathophysiology ,types, clinical manifestations, diagnosis, nursing management, medical management, nursing research .
chronic myeloid leukemia, CML, epidemiology, BCR ABL1 gene, philadelphia chromosome, t(9;22), CML incidence, etiology of CML, pathophysiology of CML, phases of CML, treatment of CML, Allogenic stem cell transplant, TKI therapy for CML, Sokal index for CML,
Hemophagocytic lymphohistiocytosis (hlh), Langerhans cell histiocytosis dr vi...Vijitha A S
Hemophagocytic lymphohistiocytosis (hlh)
Langerhans cell histiocytosis,Benign proliferation of mature histiocytes and uncontrolled phagocytosis of the platelet, erythrocytes, lymphocytes, and their hematopoietic precursors in the bonemarrow & other tissues
Leukemia, were surviving is regarded as a victory, a disease that still acts as a risk factor among the folks of Hiroshima and Nagasaki, stays as one of the fields to be looked forward for the further research. The above presentation includes the topics to be covered during a presentation on Leukemia. Apt for the students of Pharmacology.
It is a malignant disease of a blood forming organs. The common feature of leukemia is an unregulated proliferation of white blood cells (WBCs) in the bone marrow.
complete information about the cancer condition that is leukemia - introduction, definition, etiology and causes, pathophysiology ,types, clinical manifestations, diagnosis, nursing management, medical management, nursing research .
chronic myeloid leukemia, CML, epidemiology, BCR ABL1 gene, philadelphia chromosome, t(9;22), CML incidence, etiology of CML, pathophysiology of CML, phases of CML, treatment of CML, Allogenic stem cell transplant, TKI therapy for CML, Sokal index for CML,
Anesthetic Management of a Patient with Peripartum Cardiomyopathy for LUCSMd Rabiul Alam
Peripartum cardiomyopathy is one of the leading causes of death in obstetric patients since it is usually diagnosed incidentally. Echocardiogram remains the mainstay to diagnose it. Many of the peripheral hospitals are deficient of echocardiogram facilities, so there are possibilities to send the patient to OR without diagnosis. To manage such a case and bring out the success depends on quick detection of the problems & immediate medical intervention after confirming the diagnosis. Obviously, any surgical intervention requires lot of clinical experiences of the whole team, particularly the anesthesiologists.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
3. 18 Years old female
NOOR BANOO d/o
MASHOOQ, resident
of larkana, admitted
in medical unit 2
civil hospital larkana
on 28th February
2017 via emergency
with chief complain
of:
5. HOPC
According to my patient, She was in usual state of health 4
months back when she developed fever which was sudden
in onset, high grade , continued in nature, associated with
rigors & chills and with night sweats. it relieved temporarily
by taking panadol. Fever was associated with generalized
sever headache along with vomiting.
During this illness, Patient has h/o loss of appetite and
Approximately 4 to 5 kilogram loss of her body weight.
She also complained of bony pains that involved (
backbone, ribs and sternum) for last 1 to 2 months.
6. HOPC
Patient reported shortness of breath for15 days
which was gradual in onset and was progressive
that worsened with lying down & walking,
associated with chest pain.
There is no history of jaundice, rashes, burning
micturition, cough,PND, hematemesis and
hemoptysis OR joint pain.
7. PAST HISTORY
No past medical history of TB,IHD & hepatitis or
hospitalization
No h/o allergies
Pt has h/o immunization.
8. DRUG HISTORY
Tab panadol
syp lysovit
CAP risek 20 mg
There is history of transfusion of two pints of whole
blood 2 months back.
9. PERSONAL HISTORY
She is unmarried
Non smoker,
Sleep pattern is disturbed
h/o weight loss
Decreased appetite
Bladder And bowel habits are normal
10. FAMILY HISTORY
Her father and mother are healthy and normal
She has three sisters
All are healthy and normal.
11. SOCIOECONOMIC HISTORY
Patient belongs low socioeconomic status
Lives in cemented house
Father is the only earner
Hygienic conditions are satisfactory.
12. CASE SUMMURY
18 years old NOOR BANO admitted via ER with
complain of high grade, continued fever for 4 months,
associated with chills & rigors, headache and vomiting,
along with 4 to 5kg body weight loss.
Patient also complain of progressive shortness of breath
for15 days, associated with chest pain.
Patient has bony pains but no h/o jaundice, rashes, burning
micturation, cough, hematemesis , hemoptysis or joint
pains.
There is history of transfusion of two pints of whole blood
2 months back.
15. GENERAL PHYSCIAL
EXAMANITION
A young age female of average height and built ,
sitting comfortably on bed , cannulated in right
arm , well oriented with time , place and person.
18. SYSTEMIC
EXAMINATION
Central Nervous System
Higher psychiatric function : she is conscious, well oriented with time, place
and person, normal speech and intact recent and past memory
Examination of cranial nerves : all cranial nerves are intact.
Sensory system : normal
Motor functions
Bulk of muscles : normal
Tone of the muscles: increased
Power of the muscle: normal 5/5 in all limbs
Deep reflexes ( ankle , knee, biceps and triceps) : +2
Plantar reflex : up going bilaterally
signs of meningeal irritation: neck rigidity and kerning`s sign positive
19. Respiratory System
Inspection: not allowed with out clothes, apparently
shape of chest seems to be normal with reduced movements
on right side of chest
Palpation
Trachea: Central.
Apex beat: In the left 5th intercostal space in midclavicular line, 8
cm from midsternal line, normal in character
Chest expansion: Reduced (1cm)
Percussion: Area of liver dullness in 5th ICS in the right
midclavicular line
Percussion note: stony dull on right side of chest from 7th
intercostal space to down ward posteriorly
20. Auscultation :
breath sounds were diminished on right lower chest from 7th
intercostal space to downward posteriorly
Vocal resonance: reduced on right lower side of chest
posteriorly
21. Gastrointestinal System
Abdominal examination was normal except pt had
palpable spleen ,5 to 6 cm from left costal margin in anterior
axillary line with regular surface ,soft to firm in consistency and
non tender
(Liver span 12cm).
22. Cardiovascular System
Pulse rate : 108beats/min, With regular rhythm and normal
volume pulse
JVP not raised,
Apex beat: In the left 5th intercostal space in midclavicular
line, 8 cm from midsternal line, normal in character
Area of cardiac dullness: Normal.
Auscultation: . 1st and 2nd heart sounds are audible
Added sounds are not present.
23. Case Summary
18 years old NOOR BANO admitted via ER with complain of high
grade, continued fever for 4 months, associated with chills & rigors,
headache and vomiting, along with 4 to 5kg body weight loss.
Patient also complain of progressive shortness of breath for15 days,
associated with chest pain.
Patient has bony pains but no h/o jaundice, rashes, burning micturition,
cough, hematemesis , hemoptysis or joint pains.
There is history of transfusion of two pints of whole blood 2 months
back.
Examination revealed anima and bony tenderness.
Moderate splenomegaly,
Increased muscle tone with up going planters & positive SOMI
Right side of chest : Reduced chest expansion, stony dull percussion
note, reduced breath sounds & reduced VR.
44. BONE MARROW BIOPSY….
Conclusion….
BONE MARROW ASPIRATION : Hypercellular
specimen shows diffuse infiltration with blast cells
which constitute around 82% of total nucleated,
nonerythroid cells population. These blast cells are
medium in size having high nuclear to cytoplasmic
ratio, agranular cytoplasmic, fine chromatin and
inconspious nucleoli
Normally hematopoiesis is markedly suppressed
BONE MARROW TREHINE :Good length of
specimen showing effected architecture with overall
cellularity of 90 -95%. There is diffuse infiltration with
blast cells
45. Conclusion….
IMMUNOPHENOTYPE OF BLAST CELLS:
CD34 : Diffuse positive
TdT : Diffuse positive
CD79: Diffuse positive.
CD3: NEGATIVE
MPO : NEGATIVE
FINDINGS ARE CONSISTENT WITH PRECURSOR-
B CELLACUTE LYMPHOBLASTIC LEUKEMIA.
46. Conclusion…
CYTOGENETICS REPORT :
45XX,(9;22)(q34;q11.2),-20(15)
15 cells were counted, all cells were positive for
Philadelphia chromosome.
Case comment: all cells showed translocation between
chromosomes 9q34 and 22q11.2 and-20.
54. The Acute Leukemias
Acute lymphoblastic leukemia (ALL) is a malignant (clonal)
disease of the bone marrow in which early lymphoid
precursors proliferate and replace the normal
hematopoietic cells of the marrow.
The acute leukemias were usually malignancies of blast
cells with few identifying characteristics
acute lymphoid leukemias (ALLs) are pre- dominantly
cancers of children and young adults.
All lymphoid cells are derived from a common
hematopoietic pro- genitor that gives rise to lymphoid,
myeloid, erythroid, monocyte, and megakaryocyte lineage.
60. PROGNOSIS
Only 20-40% of adult with acute lymphoblast
leukemia are cured with poor risk criteria with current
treatment.
Patients with ALL are divided in to GOOD RISK and
POOR RISK CRITERIA.
61. Age younger than 30
years
WBC Count less than
30,000/uL
No adverse cytogenetics
No CNS and testicular
disease
Female patient
LDH not high
HYPERDIPLOIDY
Rapid response to
induction therapy
Age older than 60
years
Precursors B-cell
with WBC
>100,000/uL
Adverse
cytogenetics-
translocation t(9;22)
,t(4;11)
CNS or TESTICULAR
disease at
presentation
Male patient
High LDH level
HYPODIPLOIDY
No Remission in
GOOD RISK CRITERIA POOR RISK CRITERIA
65. SUPORTIVE TREATMENT
Blood transfusion for anemia, platelets
concentrates for thrombocytopenia and granulocytes
for neutrophils.
Antibiotics needed for control of infection, C0-
TRIMOXALE as prophylaxis for pneumocystis carinii
Allopurinol 10 mg/kg/day 3dd for 10 days) is given
along with induction therapy to guard against with
development of uric acid nephropathy
Adequate fluids and nutrition support
Analgesics prescribed as required .
66. Specific therapy
Traditionally there are four components of ALL
treatment
INDUCTION CHEMOTHERAPY
CONSOLIDATION CHEMOTHERAPY
MAINTENANCE CHEMOTHERAPY
CNS PROPHYLAXIS
ALL WITH CNS INVOLVEMENT
ALL WITH PHILADILPHIA CHROMOSOMES.
67.
68.
69.
70. Consolidation therapy (2-4
WEEKS)
It is given after induction therapy it removes residual
or resistant leukemic cells
regimens using a standard 4- to 5-drug induction
usually include consolidation therapy with CYTOSINE
ARABINOSIDE(Ara-C) in combination with an
anthracycline or epipodophyllotoxin.
72. CNS Prophylaxis
patients with acute lymphoblastic leukemia (ALL)
frequently have meningeal leukemia at the time of
relapse. A minority of patients have meningeal disease
at the time of initial diagnosis
high-dose systemic chemotherapy reduces CNS relapse
early intrathecal chemotherapy is to achieve the
lowest risk of CNS relapse
73. CNS relapse rates
31% for group 1 (standard chemotherapy, no CNS
prophylaxis),
18% for group 2 (high-dose systemic chemotherapy,
no CNS prophylaxis
17% for group 3 (high-dose systemic chemotherapy,
intrathecal chemotherapy for high-risk subjects after
achieving remission),
3% for group 4 hyperfractionated
cyclophosphamide, vincristine, doxorubicin, and
dexamethasone (hyper-CVAD).
74. Treatment of Ph
Chromosome–Positive ALL
the tyrosine kinase inhibitor (inhibits the bcr-abl
fusion protein of Ph+ ALL) = imatinib
Newer tyrosine kinase inhibitors
Nilotinib and dasatinib
Ponatinib
a kinase inhibitor, was approved by the US
Food and Drug Administration (FDA) in
December 2012 for patients with Ph+ ALL
that is resistant or intolerant to prior
tyrosine kinase inhibitor therapy.